Others

Outcome of Board Meeting

| Updated on November 15, 2017 Published on January 13, 2012

Bafna Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 13, 2012, inter alia, has approved the following;

1. Approved the revised facilities offered by State Bank of india, Leather & international Branch, Chennai.

2. Allotted 9,00,000 Equity Shares of Rs. 10/- each at a premium of Rs. 40/- and 25,00,000 warrants convertible into 25,00,000 equity shares of Rs. 10/- each at a premium of Rs. 40/- pursuant to In-principle approval received from the Stock Exchange.

Source : BSE - >www.bseindia.com

Published on January 13, 2012
This article is closed for comments.
Please Email the Editor